ArticleEuropean heart journal open2026

Evaluation after delayed and repeated intervention in the VIPVIZA-extended randomized controlled trial: beneficial results 6 years after baseline.

Margareta Norberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.